Eddie Hickman
Stock Analyst at Guggenheim
(0.67)
# 2354
Out of 5,343 analysts
18
Total ratings
33.33%
Success rate
8.73%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
TARS Tarsus Pharmaceutica... | Maintains: Strong Buy | 78 84 | 42.98 | 95.44% | 8 | May 2, 2025 | |
PMN ProMIS Neurosciences | Reiterates: Buy | 6 6 | 0.53 | 1032.08% | 2 | Apr 1, 2025 | |
ZVRA Zevra Therapeutics | Maintains: Strong Buy | 20 22 | 8.57 | 156.71% | 1 | Mar 13, 2025 | |
GHRS GH Research | Initiates Coverage On: Buy | 32 | 11.23 | 184.95% | 1 | Mar 13, 2025 | |
CYBN Cybin | Initiates Coverage On: Buy | 35 | 7.24 | 383.43% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 1.62 | 640.74% | 3 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | May 1, 2023 |